Crowdsourced peptide experiences
turned into simple, accessible data.

Strong approved weight and glucose-control data, with GI intolerance, dehydration, and lean-mass loss as key burdens.

Cautious gut and skin inflammation support with mostly preclinical efficacy and injection-site calming reports.

Best fit for depleted or older users seeking mitochondrial support, not stimulant-like energy.

BPC-157 has strongest signal for gut symptoms and minor tendon or ligament irritation, with cancer-context caution.

LH-mimetic support for testicular function under suppression, with estradiol as the main safety issue.

Clean GH-pulse peptide with better sleep and recovery signal than fat-loss impact, with water and glucose tradeoffs.

Confidence is strongest for soft-tissue recovery, while cancer-related angiogenesis concerns keep claims bounded.

CJC-1295 is gradual GH-axis support for sleep, recovery, and recomposition, not a GLP-1-style weight-loss tool.

ARA-290 has Phase 2 neuropathy signals and strong pain-relief reports, but use remains niche and endpoint-dependent.

A narrow late-cut tool aimed at NNMT and adipose NAD+ recycling, with no human safety trials.

Topical skin texture support has the cleanest signal; injectable use is slower, narrower, and pain-limited.

Investigational triple incretin with exceptional trial weight-loss signals and common GI escalation limits.

Best framed as resilience support for tissue stress, with healthy-user energy effects still context-dependent.

Most plausible value is preserving output during cuts or mitochondrial blocks, not dramatic standalone fat loss.

Validated GLP-1 baseline for appetite, weight, glycemic, and CV-risk signals, with GI and nutrition tradeoffs.

Clomiphene can raise LH, FSH, and testosterone when pituitary signaling is low, but visual and clot risks matter.

Short-window PDE5 vascular tool with strong ED signal; nitrate combinations can cause severe hypotension.

Most plausible late in CIRS-style neuroimmune cases, while standalone immune or longevity use remains speculative.

Reliable for erectile and urinary symptoms, with blood-pressure and pump effects more conditional.

Most compelling when immune function is low or exhausted, while already-healthy users may notice only subtle effects.